Involving clinicians in model-based designs with Non-DLT Adverse Events Integration: A safer approach to increase the performance of dose-escalation Phase I cancer trials

Posted by Evotec on Jun 20, 2024 4:36:38 PM

This poster relates to enhancing dose selection in phase I cancer trials.